ArticleThe Journal of clinical investigation2000

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.

W Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.